Steve Aselage, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 15,000 shares at $1.45 ($22K) on 2019-11-18, disclosed to the SEC on 2019-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |